Latest filing published 27 Nov 2025 for Nectar Lifesciences Limited.
Filing timeline
BuySaleSanjiv Goyal: trading record in brief
This profile gathers the share dealings of Sanjiv Goyal in Nectar Lifesciences Limited, where the filings describe the role as chief executive. Between 31 May 2021 and 27 November 2025, the trades on record add up to 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 27 November 2025, the filings show a transaction in Nectar Lifesciences Limited. Filings reach the SEBI (PIT + SAST) feed a median of 1 day after the trade. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sanjiv Goyal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,000,000 sharesEquity SharesSEBI:d5e83770c3abb3ea8a9e9e087ed2b75cece4e290
- 55,845,600 shares@ ₹15.7623.3% of flowEquity SharesSEBI:e5f0d20f8156c5b07b23dabed59438a5a104ab12
- 55,845,600 shares@ ₹15.7623.3% of flowEquity SharesSEBI:da1e5012608415661a167d2dfc6af3d5966c504b
- 55,845,600 shares@ ₹31.050.38% mcap100.0% of flowEquity SharesSEBI:b3ee334b1850baac9a94e85462fb6923f3d07650
4 of 4 declarations